Semaglutide is the drug in Wegovy and Ozempic. In 2026 you can get it online three ways: as compounded semaglutide through a telehealth program, as brand Wegovy (pill or pen) paid out of pocket, or as a brand product your insurance covers. Each one needs a prescription. The compounded route has additional regulatory and formulation questions; none of these categories guarantees a prescription or insurance coverage. For what the drug does and how well it works, see our compounded semaglutide guide.
A prescription comes first, whichever route you pick
FDA tells patients to see a doctor for the prescription and use a state-licensed pharmacy to fill it [1]. Online, that means a telehealth clinician who is licensed in the state where you live. A site that sells semaglutide after a checkbox, with no clinician review, isn't a pharmacy you should use.
| Route | Product | Who prescribes | Who dispenses | Monthly cost | Main catch |
|---|---|---|---|---|---|
| Telehealth, compounded | A specifically prescribed compounded preparation | The program's clinician, licensed in your state | A partner compounding pharmacy | Request an all-in written quote | No FDA premarket review; prescription alone does not establish all compounding conditions |
| NovoCare, Wegovy pill | FDA-approved semaglutide tablets, once daily | An authorized treating prescriber | NovoCare Pharmacy | $149 (1.5 mg), $199 (4 mg), $299 (9 and 25 mg) | Price rises as the dose steps up |
| NovoCare, Wegovy pen | FDA-approved semaglutide pens, once weekly | An authorized treating prescriber | NovoCare Pharmacy | $199 for two intro months (new patients), then $349; Wegovy HD 7.2 mg $399 | Intro price runs through December 31, 2026 |
| Telehealth, brand access | Wegovy pill or pen through a program | The program's clinician | NovoCare or a retail pharmacy | Program fee plus the medication | Check separate service and medication charges; not every service requires membership |
| Insurance | Wegovy, or Ozempic for type 2 diabetes | Your prescriber, often with prior authorization | Your pharmacy | Your copay | Coverage depends on plan and diagnosis |
NovoCare prices from Novo Nordisk's Wegovy savings-offer page; Novo Nordisk says pricing will be updated after December 31, 2026.
Route 1: a telehealth program prescribes compounded semaglutide
An online intake may be followed by clinical review, a visit, requested records or testing. If the clinician proposes a compounded product, ask what distinguishes it from an available approved product and what evidence supports the exact formulation. Do not infer approval, reliable absorption or clinical equivalence from the ingredient name or pharmacy branding.
What's legal changed in 2025. FDA ruled the semaglutide shortage resolved in February 2025. After a court denied an injunction in April 2025, the enforcement grace period for state-licensed pharmacies ended [2]. An individual prescription is one condition, rather than an automatic lawful route. FDA restricts essentially-copy compounding regularly or in inordinate amounts, and FDA spells out that "essentially a copy" includes add-in products like semaglutide with B12 when the route and strengths meet the policy’s essentially-copy criteria for the respective commercially available products.
The proposed 503B clinical-need decision concerns compounding from bulk ingredients. It does not decide every outsourcing-facility pathway or every 503A prescription. In May 2026, FDA proposed leaving semaglutide off its 503B bulks list; the reviewed notice is a proposal rather than a final determination [3]. The guide to whether compounded semaglutide will be banned tracks that docket.
Route 2: brand Wegovy, bought self-pay as a pill or a pen
Novo Nordisk now sells Wegovy straight to self-pay patients through NovoCare Pharmacy. The pill, a once-daily tablet approved in December 2025 [6], costs $149 a month at 1.5 mg, $199 at 4 mg and $299 at 9 mg and 25 mg. One month means one bottle of 30 tablets [4].
The weekly pen costs $199 a month for the first two fills at 0.25 mg and 0.5 mg if you're new to the offer, through December 31, 2026. After that it's $349 a month at every dose from 0.25 mg to 2.4 mg, and $399 for Wegovy HD 7.2 mg [4]. For how the pill compares with injections, see the oral semaglutide guide.
Some services charge separately for clinical care or membership. The Found review explains why medication, insurance-based visits and cash plans need separate quotes. The Brightmeds review distinguishes its recurring monthly GLP-1 terms from a 28-day medication supply. These examples concern commercial terms, not proof that a reader should receive a particular treatment.
Route 3: insurance covers brand semaglutide for some people
Ask the exact plan about coverage rather than assuming an advertised program accepts it. Wegovy indications differ by formulation: adult tablets and injections have weight-management and cardiovascular indications, while adolescent weight management and adult noncirrhotic MASH with moderate-to-advanced fibrosis are injection indications [5]. Ozempic is labeled for type 2 diabetes.
Ask your plan two things: is Wegovy on the formulary for your diagnosis, and does it need prior authorization? Ask about prior-authorization requirements, an applicable exception or alternative, and the actual self-pay eligibility terms. A clinician should assess appropriate options rather than choosing treatment solely by price.
Six checks before you pay a compounded semaglutide program
- Find the pharmacy. The program should name the compounding pharmacy, and that pharmacy should hold a license in your state.
- Read the active ingredient. It should say semaglutide, not semaglutide sodium or semaglutide acetate.
- Confirm the prescriber. You want a clinician licensed where you live, and a named medical group behind them.
- Work out the real monthly price. A 28-day charge interval is different from a calendar month: purchases on day zero and every 28 days require fourteen payments within the first 365 days. A 28-day supply alone does not prove that charge interval.
- Check the price at higher doses. Some programs charge one price at every dose; others raise it as you step up.
- Read the cancellation terms, especially refund rules on multi-month plans.
The salt-form check matters. FDA says some compounders sell semaglutide sodium or semaglutide acetate, which are different active ingredients from the one in approved drugs, and it knows of no lawful basis for compounding them [1].
For cost context, see the compounded semaglutide cost guide. The coverage-cost worksheet separates medication, clinical fees and insurance estimates. A provider comparison can help identify questions, but a score or lower price cannot establish product quality, eligibility or an appropriate prescription.
Red flags FDA tells consumers to watch for
FDA's list for telehealth sellers is worth reading before you sign up [1]. Warning signs include:
- A claim that the compounded drug is the same as Wegovy or Ozempic.
- A price that seems too good to be true.
- No screening, or no prescription from a licensed doctor.
- Nobody licensed to answer questions once the medicine arrives.
- A label with spelling errors, a wrong pharmacy address, or a pharmacy name you can't verify.
- Medicine that looks different from your last order, or arrives damaged or without instructions.
Two more FDA points apply once the box arrives. Don't use an injectable GLP-1 that arrives warm. FDA recommends discarding a multi-dose vial within 28 days after first puncture; an earlier beyond-use date, expiration or storage problem can require earlier disposal. The guide to storing compounded semaglutide explains both, and is compounded semaglutide safe? covers the adverse-event reports.
Drops, lozenges and dissolving tablets are not the Wegovy pill
Several programs sell compounded semaglutide you don't inject: sublingual drops, lozenges and dissolving tablets. A compounded product has no FDA premarket approval; the cited brand trials do not establish the absorption, effectiveness or safety of a different compounded formulation. This is not a claim that no human study of any oral compounded preparation exists. They're also different from the Wegovy pill, which is an approved tablet with its own label and a specific way to take it.
If a program pitches a low-dose version for wellness or longevity, the guide to microdosing GLP-1s explains what is and isn't known.
Which route fits you
Ask the clinician to identify the exact product, treatment goal and evidence, including why a compounded preparation is being proposed instead of an available approved alternative. Then request the pharmacy assignment, full quote, monitoring plan and cancellation deadline. A clear website can make these questions easier to ask, but is not independent proof of appropriate care or lawful compounding.